デフォルト表紙
市場調査レポート
商品コード
1279647

精密医療の世界市場規模調査・予測、技術別、用途別、地域別分析、2022-2029年

Global Precision Medicine Market Size study & Forecast, by Technology by Application, and Regional Analysis, 2022-2029

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
精密医療の世界市場規模調査・予測、技術別、用途別、地域別分析、2022-2029年
出版日: 2023年05月09日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

精密医療とは、患者さんの遺伝子プロファイル、生き方、環境などに着目して治療を決定する新しい科学です。

精密医療ががんの治療に成功したことで、その普及が進んでいます。医療関係者や研究者が、特定の疾患ごとに、より正確な治療や予防策を予測することが可能になるからです。精密医療は、健康な体細胞をがん化させる変異に着目したもので、個別化医療やテーラーメイド医療と呼ばれることもあります。従来の薬物療法と比較して、精密医療を用いた標的型がん治療では、副作用が少なく、早期回復を促進することができます。精密医療市場は、中枢神経系疾患の発生率の増加やがん生物学の進歩などの要因によって拡大しています。

この分野では、がんや珍しい病気を含む深刻な病気の有病率の上昇に伴い、いくつかの遺伝子治療、診断、医薬品が生み出されています。国際がん研究機関(IARC)の推計によると、世界では2018年に1,700万人のがん新規発症と950万人のがん関連死が発生しています。2040年には、全世界のがんの新規発生件数が2,750万件に増加すると推定されています。さらに、検討中の業界の発展は、細胞生物学と技術の発展によって促進されています。例えば、2021年5月、AdventHealthは、ゲノムプログラムの拡大の一環として、データ駆動型の精密医療イニシアチブを開始しました。このイニシアチブでは、縦断的な患者データと分子検査データを整理・統合し、その結果、データセットと疾患ネットワークモデルが作成され、病気の発症や治療への反応をより予測する上で医療システムを支援することになります。このように、これらの開発が成長の原動力となっています。さらに、精密医療の技術的進歩が高く、精密医療に関連する投資が増加していることが、市場に有利な成長をもたらしています。しかし、精密医療の開発には高いコストがかかるため、市場の成長を阻害しています。

精密医療の世界市場調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、その他世界のその他の地域です。北米は、ブランド技術の優位性とこの地域の疾患有病率の増加により、売上高で市場を独占しています。一方、アジア太平洋地域は、高齢者の増加、医薬品開発のための共同研究の増加、主要参入企業の地域拡大、政府機関や非営利団体の市場参入などの要因により、予測期間中に最も高いCAGRで成長すると予想されます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、競合情勢や主要企業の技術提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界市場・セグメント別市場推計・予測、2019年~2029年
    • 精密医療市場、地域別、2019年~2029年
    • 精密医療市場:技術別、2019年~2029年
    • 精密医療市場、用途別、2019年~2029年
  • 主な動向
  • 予測手法
  • 調査の前提条件

第2章 精密医療の世界市場の定義と範囲

  • 本調査の目的
  • 市場の定義とスコープ
    • 本調査の対象範囲
    • 産業の進化
  • 本調査の対象年
  • 通貨換算レート

第3章 世界の精密医療市場力学

  • 精密医療市場のインパクト分析(2019年~2029年)
    • 市場促進要因
      • 中枢神経系疾患の発生率の増加
      • がん生物学の進歩
    • 市場の課題
      • 精密医療開発のための高コスト
    • 市場機会
      • 精密医療の技術的進歩が著しい
      • 精密医療に関連する投資の拡大

第4章 世界の精密医療市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルの未来的アプローチ(2019年~2029年)
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • トップ投資機会
  • 主要成功戦略
  • 業界専門家別展望
  • アナリストの結論・提言

第5章 リスクアセスメントCOVID-19のインパクト

  • COVID-19が業界に与える全体的な影響についてのアセスメント
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 精密医療の世界市場:技術別

  • 市場スナップショット
  • 精密医療の世界市場、技術別、実績 - ポテンシャル分析
  • 精密医療の世界市場、技術別推定・予測2019-2029
  • 精密医療市場、サブセグメント別分析
    • ビッグデータアナリティクス
    • バイオインフォマティクス
    • 遺伝子シークエンス
    • 創薬
    • コンパニオン診断
    • その他の技術

第7章 精密医療の世界市場:用途別

  • 市場スナップショット
  • 精密医療の世界市場:用途別、実績-ポテンシャル分析
  • 精密医療の世界市場、用途別推定・予測2019-2029
  • 精密医療市場、サブセグメント別分析
    • オンコロジー
    • 中枢神経系
    • 免疫学
    • 呼吸器
    • その他の用途

第8章 精密医療の世界市場:地域別分析

  • 精密医療市場、地域別市場スナップショット
  • 北米
    • 米国
      • 技術別の推定・予測、2019年~2029年
      • 用途別の推定・予測、2019年~2029年
    • カナダ
  • 欧州精密医療市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域の精密医療市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの精密医療市場スナップショット
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域
  • 世界のその他の地域

第9章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Astarte Medical
      • 主要情報
      • 概要
      • 財務(データの入手が可能な場合のみ)
      • 製品概要
      • 最近の動向
    • AstraZeneca PLC
    • F Hoffmann-La Roche Ltd.
    • Laboratory Corporation of America Holdings
    • Medtronic PLC
    • Myriad Genetics Inc.
    • Novartis AG
    • Pfizer Inc.
    • Qiagen NV
    • Quest Diagnostics

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Precision Medicine Market, report scope
  • TABLE 2. Global Precision Medicine Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Precision Medicine Market estimates & forecasts by Technology 2019-2029 (USD Billion)
  • TABLE 4. Global Precision Medicine Market estimates & forecasts by Application 2019-2029 (USD Billion)
  • TABLE 5. Global Precision Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Precision Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Precision Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Precision Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Precision Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Precision Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Precision Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Precision Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Precision Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Precision Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Precision Medicine Market
  • TABLE 70. List of primary sources, used in the study of global Precision Medicine Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Precision Medicine Market, research methodology
  • FIG 2. Global Precision Medicine Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Precision Medicine Market, key trends 2021
  • FIG 5. Global Precision Medicine Market, growth prospects 2022-2029
  • FIG 6. Global Precision Medicine Market, porters 5 force model
  • FIG 7. Global Precision Medicine Market, pest analysis
  • FIG 8. Global Precision Medicine Market, value chain analysis
  • FIG 9. Global Precision Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Precision Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Precision Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Precision Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Precision Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Precision Medicine Market, regional snapshot 2019 & 2029
  • FIG 15. North America Precision Medicine Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Precision Medicine Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Precision Medicine Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Precision Medicine Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Precision Medicine Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Precision Medicine Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Precision medicine is an emerging science that focuses treatment decisions on a patient's genetic profile, way of life, and environment. The success of precision medicine in treating cancer has led to an increase in its popularity. It enables medical professionals and researchers to forecast more precise treatment and prevention measures for every specific disease. Precision medicine, which focuses on the mutations that turn healthy bodily cells into cancerous ones, is often referred to as personalized medicine or tailored medicine. In comparison to conventional medications, the use of precision medicine in targeted cancer treatment offers fewer adverse effects and promotes faster recovery. The Precision Medicine market is expanding because of factors such as increasing incidence of central nerves system disorders and advancement in cancer biology.

Several gene therapies, diagnostics, and medications have been created in this field as a result of the rise in the prevalence of serious illnesses including cancer and uncommon diseases. According to estimates from the International Agency for Research on Cancer (IARC), globally, there were 17.0 million new instances of cancer and 9.5 million cancer-related deaths in 2018. It is estimated to increase the worldwide burden of cancer to 27.5 million new cases by 2040. Furthermore, the development of the industry under review is being fueled by developments in cell biology and technology. For instance, in May 2021, AdventHealth launched a data-driven precision medicine initiative as part of the expansion of its genomics programme. This initiative organize and integrate longitudinal patient data with molecular testing data, resulting in the creation of a dataset and disease network models that will aid the healthcare system in better anticipating the onset of diseases and how they will respond to treatments. Thus, these developments are fueling the growth. In addition, higher technological advancements of precision medicine and growing investments associated with precision medicine is creating a lucrative growth to the market. However, high cost for precision medicine development halt market growth.

The key regions considered for the Global Precision Medicine Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded Technologies and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric, an increase in the number of collaborations for medicine development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

  • Astarte Medical
  • AstraZeneca PLC
  • F Hoffmann-La Roche Ltd.
  • Laboratory Corporation of America Holdings
  • Medtronic PLC
  • Myriad Genetics Inc.
  • Novartis AG
  • Pfizer Inc.
  • Qiagen NV
  • Quest Diagnostics

Recent Developments in the Market:

  • In November 2022, The University of Pecs (UP) and BGI Genomics decided to open a collaborative lab in Hungary. The collaborative lab will begin formal operations in order to strengthen BGI Genomics' and the UP's avant-garde precision medicine advancements in the Central and Eastern European region and to speed the development of genomic sequencing and clinical diagnostic services.

Global Precision Medicine Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Technology, Application, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Technology:

  • Big Data Analytics
  • Bioinformatics
  • Gene Sequencing
  • Drug Discovery
  • Companion Diagnostics
  • Other Technologies

By Application:

  • Oncology
  • CNS
  • Immunology
  • Respiratory
  • Other Applications

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Precision Medicine Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Precision Medicine Market, by Technology, 2019-2029 (USD Billion)
    • 1.2.3. Precision Medicine Market, by Application, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Precision Medicine Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Precision Medicine Market Dynamics

  • 3.1. Precision Medicine Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of Central Nerves System disorders
      • 3.1.1.2. Advancement in Cancer Biology
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost for precision medicine development
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Higher Technological Advancements of Precision Medicine
      • 3.1.3.2. Growing Investments Associated with Precision Medicine

Chapter 4. Global Precision Medicine Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Precision Medicine Market, by Technology

  • 6.1. Market Snapshot
  • 6.2. Global Precision Medicine Market by Technology, Performance - Potential Analysis
  • 6.3. Global Precision Medicine Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
  • 6.4. Precision Medicine Market, Sub Segment Analysis
    • 6.4.1. Big Data Analytics
    • 6.4.2. Bioinformatics
    • 6.4.3. Gene Sequencing
    • 6.4.4. Drug Discovery
    • 6.4.5. Companion Diagnostics
    • 6.4.6. Other Technologies

Chapter 7. Global Precision Medicine Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Precision Medicine Market by Application, Performance - Potential Analysis
  • 7.3. Global Precision Medicine Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
  • 7.4. Precision Medicine Market, Sub Segment Analysis
    • 7.4.1. Oncology
    • 7.4.2. CNS
    • 7.4.3. Immunology
    • 7.4.4. Respiratory
    • 7.4.5. Other Applications

Chapter 8. Global Precision Medicine Market, Regional Analysis

  • 8.1. Precision Medicine Market, Regional Market Snapshot
  • 8.2. North America Precision Medicine Market
    • 8.2.1. U.S. Precision Medicine Market
      • 8.2.1.1. Technology breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Precision Medicine Market
  • 8.3. Europe Precision Medicine Market Snapshot
    • 8.3.1. U.K. Precision Medicine Market
    • 8.3.2. Germany Precision Medicine Market
    • 8.3.3. France Precision Medicine Market
    • 8.3.4. Spain Precision Medicine Market
    • 8.3.5. Italy Precision Medicine Market
    • 8.3.6. Rest of Europe Precision Medicine Market
  • 8.4. Asia-Pacific Precision Medicine Market Snapshot
    • 8.4.1. China Precision Medicine Market
    • 8.4.2. India Precision Medicine Market
    • 8.4.3. Japan Precision Medicine Market
    • 8.4.4. Australia Precision Medicine Market
    • 8.4.5. South Korea Precision Medicine Market
    • 8.4.6. Rest of Asia Pacific Precision Medicine Market
  • 8.5. Latin America Precision Medicine Market Snapshot
    • 8.5.1. Brazil Precision Medicine Market
    • 8.5.2. Mexico Precision Medicine Market
    • 8.5.3. Rest of Latin America Precision Medicine Market
  • 8.6. Rest of The World Precision Medicine Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Astarte Medical
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. AstraZeneca PLC
    • 9.2.3. F Hoffmann-La Roche Ltd.
    • 9.2.4. Laboratory Corporation of America Holdings
    • 9.2.5. Medtronic PLC
    • 9.2.6. Myriad Genetics Inc.
    • 9.2.7. Novartis AG
    • 9.2.8. Pfizer Inc.
    • 9.2.9. Qiagen NV
    • 9.2.10. Quest Diagnostics

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption